Sign in

CIK 0001607678 · Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461073877
Phone
858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. 4 Grant or award Director acquired 6,333 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale President & CEO sold 148,517 shares at $33.32 ($4,947,888)
  4. 4 Open-market sale Chief Financial Officer sold 21,217 shares at $33.47 ($710,141)
  5. 4 Open-market sale Chief Operating Officer sold 18,217 shares at $33.47 ($609,636)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Commercial Officer bought 4,475 shares at $33.50 ($149,913)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Financial Officer sold 57,661 shares at an average $32.90 ($1,896,969)
  12. 4 Open-market sale Chief Operating Officer sold 57,661 shares at an average $32.98 ($1,901,405)
  13. 4 Open-market sale President & CEO sold 233,409 shares at an average $32.96 ($7,692,121)
  14. 4 Grant or award Director acquired 3,150 shares (grant or award)
  15. 4 Grant or award Director acquired 3,150 shares (grant or award)
  16. 4 Grant or award Director acquired 3,150 shares (grant or award)
  17. 4 Open-market sale Director sold 16,000 shares at $35.11 ($561,694)
  18. 4 Grant or award Director acquired 3,150 shares (grant or award)
  19. 4 Open-market sale Chief Operating Officer sold 6,185 shares at $35.00 ($216,492)
  20. 4 Open-market sale Director sold 60,000 shares at $35.57 ($2,134,278)

Page 1 of 11 · 216 filings